AKT1 and hereditary clear cell renal cell carcinoma: For example, the PI3K-AKT pathway is downregulated by the combined treatment with URB597 (FAAH inhibitor) and RSL3 (ferroptosis inducer) in renal cell carcinoma (RCC) cells.